SCLX Stock Analysis: Buy, Sell, or Hold?
SCLX - Scilex Holding Company Common Stock
$6.95
0.04 (0.65%)
▲
5d:
+16.53%
30d:
-10.96%
90d:
-38.76%
BUY
HIGH Confidence
Analysis Updated: Apr 20, 2026 12:00 AM ET
Earnings: May 13, 2026
21d
Get Alerted When SCLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SCLX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SCLX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.19
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.60
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SCLX is currently trading at $6.95, which is considered fair relative to its 30-day fair value range of $6.38 to $7.68. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.5) compared to its historical average (4.1). At these levels, the market is pricing in 32.8% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, SCLX is in a strong downtrend. Immediate support is located at $4.20, while resistance sits at $7.77.
Market Sentiment: SCLX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $490.00 (+6955.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SCLX is in a strong downtrend. Immediate support is located at $4.20, while resistance sits at $7.77.
Market Sentiment: SCLX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $490.00 (+6955.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$6.38 -
$7.68
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 6955.4% below Wall St target ($490.00)
- BEARISH: Market expects 32.8% growth - appears too optimistic based on history
Fair Price Analysis
30-Day Fair Range
$6.38 -
$7.68
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$4.20
Resistance Level
$7.77
Current Trend
Strong Downtrend
Technical data as of
Apr 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.51
Wall Street Target
$490.00
(+6955.4%)
Revenue Growth (YoY)
-67.8%
Valuation Premium vs History
+32.8% premium
PE vs Historical
9.5 vs 4.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+32.8%
(market-implied from PE analysis)
1-Year Target
$9.22
(+33%)
2-Year Target
$12.25
(+76%)
3-Year Target
$16.27
(+134%)
3-Yr Target (if PE normalizes)
(PE: 10→4)
PE COMPRESSION
$7.01
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: April 21, 2026 9:22 AM ET
Data refreshes hourly during market hours. Next update: 10:22 AM
Data refreshes hourly during market hours. Next update: 10:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1210 | 62 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 60 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$207 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$352 | 62 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$249 | 61 BUY |
